ESMERALDA SCOTT: Open Payments
NPI 1528652948 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 18 payments from 10 companies in 2025. Trend: 2023 $1,058 · 2024 $541 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $210 |
| Dexcom, Inc. | 1 | $148 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| SANOFI-AVENTIS U.S. LLC | 2 | $46 |
| Dynavax Technologies Corporation | 2 | $26 |
| Tris Pharma Inc | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $15 |
Products named: Ozempic, DEXCOM G7 GSS (161), BREZTRI, TZIELD, Heplisav-B, Dyanavel XR, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
